Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet hyperaggregability in cystic fibrosis.

R J Stead, M A Barradas, D P Mikhailidis

    Prostaglandins, Leukotrienes, and Medicine
    |February 1, 1987
    PubMed
    Summary

    Platelets in cystic fibrosis (CF) patients show heightened reactivity to common stimuli, releasing more thromboxane A2 (TXA2). This platelet hyperaggregability may contribute to CF-related bronchoconstriction.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Endocrine Disorders and Peripheral Arterial Disease - A Series of Reviews Cushing Syndrome-Cortisol Excess.

    Current vascular pharmacology·2023
    Same author

    Growth Hormone, Atherosclerosis and Peripheral Arterial Disease: Exploring the Spectrum from Acromegaly to Growth Hormone Deficiency.

    Current vascular pharmacology·2023
    Same author

    Nonalcoholic Fatty Pancreas Disease: Role in Metabolic Syndrome, "Prediabetes," Diabetes and Atherosclerosis.

    Digestive diseases and sciences·2021
    Same author

    Multifocal arterial disease: clinical implications and management.

    Current opinion in cardiology·2020
    Same author

    Preface.

    Current vascular pharmacology·2018
    Same author

    Daylight saving time and myocardial infarction: should we be worried? A review of the evidence.

    European review for medical and pharmacological sciences·2018

    Area of Science:

    • Hematology
    • Pulmonology
    • Biochemistry

    Background:

    • Cystic Fibrosis (CF) is a genetic disorder affecting multiple organs.
    • Platelet activation and function in CF are not fully understood.
    • Potential links between platelet activity and CF-related complications warrant investigation.

    Purpose of the Study:

    • To investigate platelet function in patients with cystic fibrosis.
    • To compare platelet aggregability and thromboxane A2 (TXA2) release in CF patients versus healthy controls.
    • To explore the potential clinical relevance of altered platelet function in CF pathogenesis.

    Main Methods:

    • Platelet-rich plasma (PRP) was prepared from 15 CF patients and 10 age-matched controls.
    • Platelet aggregation was induced using adrenaline, collagen, and arachidonic acid.

    Related Experiment Videos

  • Thromboxane A2 (TXA2) release was measured.
  • Platelet counts, body weight, and vitamin E supplementation were considered.

    • Main Results:

    • Patients with CF exhibited marked platelet hyperaggregability to adrenaline, collagen, and arachidonic acid.
    • Significantly enhanced Thromboxane A2 (TXA2) release was observed in CF platelets.
    • Platelet hyperaggregability and increased TXA2 release were independent of platelet count, body weight, and vitamin E status.

    Conclusions:

    • Platelets from CF patients display enhanced aggregability and increased TXA2 production.
    • This platelet hyperreactivity may play a role in the pathogenesis of bronchoconstriction in CF.
    • Further research is needed to elucidate the mechanisms and clinical implications of platelet dysfunction in cystic fibrosis.